:
Hierarchie
Untercodes
  • 6-003.c Ranibizumab, intravitreal
  • 6-003.d Pegaptanib, intravitreal
  • 6-003.1 Amphotericin-B-Lipidkomplex, parenteral
  • 6-003.2 Palifermin, parenteral
  • 6-003.3 Carmustin-Implantat, intrathekal
  • 6-003.4 Dibotermin alfa, Implantation am Knochen
  • 6-003.5 Eptotermin alfa, Implantation am Knochen
  • 6-003.a Sunitinib, oral
  • 6-003.b Sorafenib, oral
  • 6-003.e Nelarabin, parenteral
  • 6-003.f Natalizumab, parenteral
  • 6-003.g Lenalidomid, oral
  • 6-003.h Eculizumab, parenteral
  • 6-003.j Clofarabin, parenteral
  • 6-003.k Anidulafungin, parenteral
  • 6-003.s Abatacept, intravenös
  • 6-003.t Abatacept, subkutan
  • 6-003.6 Radioimmuntherapie mit 90Y-Ibritumomab-Tiuxetan, parenteral
  • 6-003.7 Enzymersatztherapie bei lysosomalen Speicherkrankheiten
  • 6-003.8 Botulinumtoxin
  • 6-003.9 Surfactantgabe bei Neugeborenen
  • 6-003.n Nicht pegylierte Asparaginase, parenteral
  • 6-003.p Pegylierte Asparaginase, parenteral
  • 6-003.q Dexrazoxan, parenteral
  • 6-003.r L-Asparaginase aus Erwinia chrysanthemi [Erwinase], parenteral
Links